![We Care for Every Heartbeat]({"type":"image" , "src" : "/sda/112416/JournalAd-TACD-Daiichi.jpg"})
https://orcid.org/0000-0002-1350-959X
References
- Gottdiener JS, Kitzman DW, Aurigemma GP, et al. Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study)). Am J Cardiol. 2006;97(1):83–89.
- Hoit BD. Left atrial size and function, role in prognosis. J Am Coll Cardiol. 2014;63(6):493–505.
- Quinones MA, Greenberg BH, Kopelen HA, et al. Echocardiographic predictors of clinical outcome in patients with left ventric- ular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. J Am Coll Cardiol. 2000;35(5):1237–1242.
- Rossi A, Temporelli PL, Quintana M, on behalf of the MeRGE Heart Failure Collaborators, et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail. 2009;11(10):929–936.
- Priori SG, Blomström-Lundqvist C, Mazzanti A, ESC Scientific Document Group, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867.
- van Welsenes GH, van Rees JB, Borleffs CJ, et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace. 2011;13(3):389–394.
- Køber L, Thune JJ, Nielsen JC, DANISH Investigators, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221–1230.
- Gracieux J, Sanders GD, Pokorney SD, et al. Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review. Int J Cardiol. 2014;177(3):990–994.
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.
- Kaplan A, Gurdal A, Akdeniz C, et al. The relationship between left atrial volume and ventricular arrhythmias in the patients with dilated cardiomyopathy. Int Cardiovasc Res J. 2014;8:18–23.
- Rossi A, Cicoira M, Zanolla L, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40(8):1425–1430.
- Tamura H, Watanabe T, Nishiyama S, et al. Increased left atrial volume index predicts a poor prognosis in patients with heart failure. J Card Fail. 2011;17(3):210–216.
- Ristow B, Ali S, Whooley MA, et al. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol. 2008;102(1):70–76.
- Negishi K, Negishi T, Zardkoohi O, et al. Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17(10):1153–1160.
- Kayataş M, Ozdemir FN, Muderrisoglu H, et al. Diastolic dysfunction increases the frequency of ventricular arrhythmia in hemodialysis patients. Nephron. 1999;82(2):185–187.
- Lerman BB, Engelstein ED, Burkhoff D. Mechanoelectrical feedback: role of beta-adrenergic receptor activation in mediating load-dependent shortening of ventricular action potential and refractoriness. Circulation. 2001;104(4):486–490.
- Rijnierse MT, Kamali Sadeghian M, Schuurmans Stekhoven S, et al. Usefulness of left atrial emptying fraction to predict ventricular arrhythmias in patients with implantable cardioverter defibrillators. Am J Cardiol. 2017;120(2):243–250.
- Greenlee RT, Go AS, Peterson PN, et al. Device therapies among patients receiving primary prevention implantable cardioverter-defibrillators in the cardiovascular research network. J Am Heart Assoc. 2018;7:e008292.
- Verma A, Sarak B, Kaplan AJ, et al. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33(3):320–329.
- Daubert JP, Zareba W, Cannom DS, Investigators MI, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–1365.
- Safak E, Eckardt L, Jung W, et al. Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective. J Interv Card Electrophysiol. 2019;56(1):71–77.
- Giancaterino S, Nishimura M, Birgersdotter-Green U, et al. Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement. Pacing Clin Electrophysiol. 2020;43(6):542–550.
- Seko Y, Kato T, Haruna T, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8(1):6366.
- Thomas L, Abhayaratna WP. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imag. 2017;10(1):65–77.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})